These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9354616)

  • 1. Catalytic domain structure of vampire bat plasminogen activator: a molecular paradigm for proteolysis without activation cleavage.
    Renatus M; Stubbs MT; Huber R; Bringmann P; Donner P; Schleuning WD; Bode W
    Biochemistry; 1997 Nov; 36(44):13483-93. PubMed ID: 9354616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 2.3 A crystal structure of the catalytic domain of recombinant two-chain human tissue-type plasminogen activator.
    Lamba D; Bauer M; Huber R; Fischer S; Rudolph R; Kohnert U; Bode W
    J Mol Biol; 1996 Apr; 258(1):117-35. PubMed ID: 8613982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysine 156 promotes the anomalous proenzyme activity of tPA: X-ray crystal structure of single-chain human tPA.
    Renatus M; Engh RA; Stubbs MT; Huber R; Fischer S; Kohnert U; Bode W
    EMBO J; 1997 Aug; 16(16):4797-805. PubMed ID: 9305622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural features mediating fibrin selectivity of vampire bat plasminogen activators.
    Bringmann P; Gruber D; Liese A; Toschi L; Krätzchmar J; Schleuning WD; Donner P
    J Biol Chem; 1995 Oct; 270(43):25596-603. PubMed ID: 7592732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of specific inhibition of urokinase plasminogen activator by amiloride.
    Jankun J; Skrzypczak-Jankun E
    Cancer Biochem Biophys; 1999 Jul; 17(1-2):109-23. PubMed ID: 10738907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Construction of Pichia pastoris strain expressing salivary plasminogen activator from vampire bat (Desmodus rotundus)].
    Liu Y; Su C; Song X; Tang Y; Bao Z
    Sheng Wu Gong Cheng Xue Bao; 2009 Apr; 25(4):566-74. PubMed ID: 19637633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Function of the central domain of streptokinase in substrate plasminogen docking and processing revealed by site-directed mutagenesis.
    Chaudhary A; Vasudha S; Rajagopal K; Komath SS; Garg N; Yadav M; Mande SC; Sahni G
    Protein Sci; 1999 Dec; 8(12):2791-805. PubMed ID: 10631997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
    Dekker RJ; Eichinger A; Stoop AA; Bode W; Pannekoek H; Horrevoets AJ
    J Mol Biol; 1999 Oct; 293(3):613-27. PubMed ID: 10543954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagenesis at Pro309 of single-chain urokinase-type plasminogen activator alters its catalytic properties.
    Sun Z; Liu JN
    Proteins; 2005 Dec; 61(4):870-7. PubMed ID: 16231330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional roles of streptokinase C-terminal flexible peptide in active site formation and substrate recognition in plasminogen activation.
    Zhai P; Wakeham N; Loy JA; Zhang XC
    Biochemistry; 2003 Jan; 42(1):114-20. PubMed ID: 12515545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein(a): structure-function relationship at the lysine-binding site and plasminogen activator cleavage site.
    Anglés-Cano E; Rojas G
    Biol Chem; 2002 Jan; 383(1):93-9. PubMed ID: 11928826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory mechanism of serpins: loop insertion forces acylation of plasminogen activator by plasminogen activator inhibitor-1.
    Kvassman JO; Verhamme I; Shore JD
    Biochemistry; 1998 Nov; 37(44):15491-502. PubMed ID: 9799512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of active site-inhibited human coagulation factor VIIa (des-Gla).
    Kemball-Cook G; Johnson DJ; Tuddenham EG; Harlos K
    J Struct Biol; 1999 Oct; 127(3):213-23. PubMed ID: 10544046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model for substrate interactions in C5a peptidase from Streptococcus pyogenes: A 1.9 A crystal structure of the active form of ScpA.
    Kagawa TF; O'Connell MR; Mouat P; Paoli M; O'Toole PW; Cooney JC
    J Mol Biol; 2009 Feb; 386(3):754-72. PubMed ID: 19152799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The structure of truncated recombinant human bile salt-stimulated lipase reveals bile salt-independent conformational flexibility at the active-site loop and provides insights into heparin binding.
    Moore SA; Kingston RL; Loomes KM; Hernell O; Bläckberg L; Baker HM; Baker EN
    J Mol Biol; 2001 Sep; 312(3):511-23. PubMed ID: 11563913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrin selectivity of the isolated protease domains of tissue-type and vampire bat salivary gland plasminogen activators.
    Toschi L; Bringmann P; Petri T; Donner P; Schleuning WD
    Eur J Biochem; 1998 Feb; 252(1):108-12. PubMed ID: 9523718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activators from the saliva of Desmodus rotundus (common vampire bat): unique fibrin specificity.
    Schleuning WD; Alagon A; Boidol W; Bringmann P; Petri T; Krätzschmar J; Haendler B; Langer G; Baldus B; Witt W
    Ann N Y Acad Sci; 1992 Dec; 667():395-403. PubMed ID: 1309059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and functional basis of plasminogen activation by staphylokinase.
    Jespers L; Vanwetswinkel S; Lijnen HR; Van Herzeele N; Van Hoef B; Demarsin E; Collen D; De Maeyer M
    Thromb Haemost; 1999 Apr; 81(4):479-85. PubMed ID: 10235424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of the human carboxypeptidase N (kininase I) catalytic domain.
    Keil C; Maskos K; Than M; Hoopes JT; Huber R; Tan F; Deddish PA; Erdös EG; Skidgel RA; Bode W
    J Mol Biol; 2007 Feb; 366(2):504-16. PubMed ID: 17157876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of human pro-chymase: a model for the activating transition of granule-associated proteases.
    Reiling KK; Krucinski J; Miercke LJ; Raymond WW; Caughey GH; Stroud RM
    Biochemistry; 2003 Mar; 42(9):2616-24. PubMed ID: 12614156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.